Justices Jilt Pfizer's Kickback Attack, But Dispute Isn't Done
The U.S. Supreme Court refused Monday to entertain Pfizer's high-profile challenge to a powerful kickback law that has generated billions of dollars in fraud settlements, but the underlying controversy continues in...To view the full article, register now.
Already a subscriber? Click here to view full article